CN Stock MarketDetailed Quotes

688046 GemPharmatech

Watchlist
  • 14.37
  • +0.51+3.68%
Noon Break Dec 2 11:29 CST
5.89BMarket Cap42.26P/E (TTM)

GemPharmatech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GemPharmatech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Apr 27, 20242024/Q1157.087M / 154.000M--
DatePeriodRevenue/EstimateEarnings Call
Apr 27, 20242024/Q1157.087M / 154.000M--

GemPharmatech Earnings Reports

  • Yakkang Biotech: Yakang Biotech Report for the Third Quarter of 2024

    Oct 31 00:00

  • Yakkang Biotech Report for the Third Quarter of 2024

    Oct 31 00:00

  • Yakkang Biotech 2024 Semi-Annual Report

    Aug 29 00:00

  • Summary of Yakkang Biotech\'s 2024 Semi-Annual Report

    Aug 29 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 1, 2024

    Strong Buy

    • Strong Buy

      50.00%

    • Buy

      50.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data